CytoCore Inc. (OTCMKTS:MDIT) Sees Large Growth in Short Interest

CytoCore Inc. (OTCMKTS:MDIT – Get Free Report) was the target of a significant increase in short interest in the month of May. As of May 29th, there was short interest totaling 30 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average daily volume of 7 shares, the days-to-cover ratio is presently 4.3 days.

CytoCore Stock Down 100.0%

CytoCore has a 12-month low of $0.00 and a 12-month high of $0.00.

About CytoCore

(Get Free Report)

Medite Cancer Diagnostics, Inc operates as a medical technology company. It develops, manufactures, and markets molecular biomarkers, medical devices, and consumables for the detection, risk assessment, and diagnosis of cancerous and precancerous conditions and related diseases. The company offers USE 33, an ultrasonic decalcification instrument that automatically runs the process under controlled temperatures; TPC 15 Duo and Trio, a tissue processing instrument; TES 99 and TES Valida cooling units; and M530, A550, M380 microtomes for tissue sectioning.

Read More

• Five stocks we like better than CytoCore
• These 5 Companies Just Made a Massive Bet on Themselves
• 5 Stocks Built to Thrive in a Higher-for-Longer Economy
• RH’s Strong Q1 Still Leaves Investors With One Big Question
• Iran Ceasefire or Not, These 3 Companies Could Win